0001209191-19-053134.txt : 20191015 0001209191-19-053134.hdr.sgml : 20191015 20191015160330 ACCESSION NUMBER: 0001209191-19-053134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191014 FILED AS OF DATE: 20191015 DATE AS OF CHANGE: 20191015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wilson Jason Douglas CENTRAL INDEX KEY: 0001662395 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37785 FILM NUMBER: 191150994 MAIL ADDRESS: STREET 1: C/O REATA PHARMACEUTICALS, INC. STREET 2: 2801 GATEWAY DR. SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001358762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113651945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 BUSINESS PHONE: 972-865-2206 MAIL ADDRESS: STREET 1: 2801 GATEWAY DRIVE SUITE 150 CITY: IRVING STATE: TX ZIP: 75063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-14 0 0001358762 REATA PHARMACEUTICALS INC RETA 0001662395 Wilson Jason Douglas 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 0 1 0 0 Executive VP of Operations Class A common stock 2019-10-14 4 C 0 15000 A 22350 D Class A common stock 2019-10-14 4 S 0 15000 100.00 D 7350 D Class A common stock 2019-10-15 4 C 0 15000 A 22350 D Class A common stock 2019-10-15 4 S 0 11800 145.5452 D 10550 D Class A common stock 2019-10-15 4 S 0 300 146.6117 D 10250 D Class A common stock 2019-10-15 4 S 0 2900 148.4619 D 7350 D Class B common stock 2019-10-14 4 C 0 15000 D Class A common stock 15000 33827 D Class B common stock 2019-10-15 4 C 0 15000 D Class A common stock 15000 18827 D The conversions and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2018. The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $145.26 to $145.855. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $146.48 to $146.775. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $148.22 to $149.04. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Michael D. Wortley, attorney-in-fact 2019-10-15